Drug Database
Back to search

Switzerland· 56120003

Remodulin 2.5 mg/ml, Infusionslösung s.c. und i.v.

A treprostinil product containing treprostinilum, registered in Switzerland by Gebro Pharma AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC B01AC21

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedRemodulin 2.5 mg/ml, Infusionslösung …ATCB01AC21REGISTER NO.56120003PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about treprostinilumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Treprostinil is registered in 17 of 19 countries.

Countries holding a registration under ATC B01AC21 (treprostinil), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 9 of them publish a price we can compare per daily dose
Search treprostinil products by name

Treprostinil · ATC B01AC21

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
treprostinilum
Manufacturer
Gebro Pharma AG
Country
Switzerland (CH)
ATC code
B01AC21
ATC class
Treprostinil
Defined daily dose
4.3 mg, P
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680561200038
    Vial 20 ml
    CHF 3762.35

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

371 interactions on record for treprostinil.

Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check treprostinil against other medicinesHow interaction checks work

Treprostinil · interactions on record

371 records

  • 34 severe
  • 295 moderate
  • 2 minor
  • 40 info

Most severe, free to view

  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • DanaparoidB01AB09severe
  • TinzaparinB01AB10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Treprostinil in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All treprostinil products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Remodulin, Treposa
  • Belgium · Remodulin, Tresuvi
  • Bulgaria · Тресуви
  • Cyprus · Remodulin
  • Czechia · Remodulin, Treprostinil Tillomed
  • Germany · Remodulin, Treprostinil Beta
  • Denmark · Remodulin, Treprostinil Tillomed
  • Estonia · Remodulin, Tresuvi
  • Spain · Treprostinilo Dr. Reddys, Treprostinilo Ferrer
  • Finland · Remodulin, Treposa
  • France · Remodulin, Treposuvi
  • United Kingdom (Northern Ireland) · Treprostinil Dr. Reddy's Laboratories (Uk), Treprostinil Tillomed
  • Greece · Remodulin, Treprostinil Tillomed
  • Croatia · Remodulin, Treprostinil Tillomed
  • Hungary · Remodulin, Treprostinil Zentiva
  • Ireland · Treposuvi, Treprostinil Tillomed
  • Iceland · Remodulin, Trepulmix
  • Italy · Remodulin, Treprostinil Dr. Reddy’s
  • Liechtenstein · Trepulmix
  • Lithuania · Remodulin, Treprostinil Tillomed
  • Luxembourg · Remodulin
  • Latvia · Remodulin, Treposuvi
  • Malta · Tresuvi
  • Netherlands · Remodulin, Treposuvi
  • Norway · Remodulin, Treprostinil Tillomed
  • Poland · Remodulin, Treprostinil Reddy
  • Portugal · Remodulin, Treprostinilo Tillomed
  • Romania · Tresuvi
  • Sweden · Remodulin, Treprostinil Tillomed
  • Slovenia · Remodulin, Treprostinil Amomed
  • Slovakia · Remodulin, Treprostinil Tillomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/31661738-0af0-4243-bf27-be9f2d4f37b0
GET /v1/drugs/31661738-0af0-4243-bf27-be9f2d4f37b0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "treprostinilum 50 mg",
  "valid_from": "2007-01-01",
  "limitations": "[{\"description\":\"Langzeitbehandlung von pulmonaler Hypertonie und pulmonal arterieller Hypertonie mit Bindegewebserkrankung bei Patienten mit NYHA III und IV (Einteilung nach der New York Heart Association).<br>\\nBei Patienten mit NYHA Class III bei Versagen der oralen und inhalativen Therapie.\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2007-01-01\"}]",
  "galenic_form": "Inf Lös 50 mg/20ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "2007-01-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about treprostinil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console